everi
envelop
viru
fuse
membran
host
cell
membran
therebi
releas
genom
cytoplasm
initi
viral
replic
cycl
case
one
small
set
viral
surfac
transmembran
glycoprotein
mediat
fusion
viral
fusion
protein
vari
mode
activ
structur
class
featur
combin
yield
mani
differ
fusion
mechan
despit
differ
common
principl
fusion
protein
function
emerg
respons
activ
trigger
metast
fusion
protein
convert
extend
case
rodlik
structur
insert
target
membran
via
fusion
peptid
subsequ
conform
chang
caus
fusion
protein
fold
back
upon
therebi
bring
fusion
peptid
transmembran
domainand
attach
target
viral
membranesinto
intim
contact
fusion
ensu
initi
lipid
stalk
progress
local
hemifus
open
enlarg
fusion
pore
review
recent
advanc
understand
fusion
protein
activ
fusion
protein
chang
conform
fusion
happen
lipid
fusion
also
briefli
discuss
therapeut
potenti
fusion
inhibitor
treat
viral
infect
introduct
fusion
envelop
virus
host
cell
remain
import
topic
research
two
major
reason
first
recent
becom
clear
fusion
good
target
therapeut
intervent
kilbi
et
al
second
viral
fusion
reaction
continu
serv
model
cellular
fusion
event
although
sever
viral
fusion
protein
influenza
hemagglutinin
ha
human
immunodefici
viru
hiv
envelop
glycoprotein
env
emerg
paradigm
import
realiz
mani
distinguish
featur
among
viral
fusion
protein
tabl
viral
fusion
protein
activ
fusion
differ
mechan
also
classifi
accord
structur
criteria
virus
viral
receptor
activ
particip
fusion
wherea
other
one
receptor
essenti
player
locat
fusion
peptid
critic
fusion
vari
final
wherea
virus
requir
singl
viral
glycoprotein
mediat
fusion
other
requir
multipl
viral
glycoprotein
mani
excel
recent
review
viral
fusion
glycoprotein
mediat
process
durel
et
al
eckert
kim
heinz
allison
skehel
wiley
weissenhorn
et
al
goal
review
give
reader
appreci
divers
viral
fusion
mechan
fusion
protein
exist
virion
surfac
metast
state
fusion
peptid
critic
hydrophob
sequenc
hidden
shield
within
glycoprotein
oligom
carr
et
al
hernandez
et
al
rey
et
al
skehel
wiley
wilson
et
al
activ
fusion
peptid
render
access
interact
target
membran
major
distinct
among
viral
fusion
protein
trigger
activ
two
wellrecogn
mechan
exposur
low
ph
specif
interact
target
cell
receptor
neutral
ph
third
mechan
involv
receptor
prime
neutral
ph
follow
activ
low
ph
recent
propos
moth
et
al
orthomyxovirus
togavirus
flavivirus
rhabdovirus
bunyavirus
arenavirus
appar
filovirus
requir
low
ph
fuse
target
membran
tabl
dom
et
al
gaudin
et
al
stegmann
et
al
virus
endocytos
bind
target
cell
surfac
lowph
environ
endosom
activ
viral
fusion
protein
convert
metast
state
one
capabl
drive
fusion
although
presenc
receptor
may
modul
rate
extent
fusion
stegmann
et
al
white
et
al
receptor
essenti
lowphdepend
fusion
lowphdepend
fusion
gener
occur
within
second
minut
also
occur
albeit
slowli
four
main
techniqu
use
assess
whether
viru
requir
low
ph
fuse
first
techniqu
test
effect
agent
bafilomycin
inhibit
endosom
acidif
studi
type
fusion
measur
directli
assess
transfer
fluoresc
probe
viru
target
cell
earp
et
al
irurzun
et
al
zarkik
et
al
other
fusion
infer
monitor
postfus
event
synthesi
viral
dna
moth
et
al
second
test
assess
whether
fusion
bound
virion
induc
briefli
warm
viruscel
complex
lowph
medium
moth
et
al
third
test
assess
whether
pretreat
virion
low
ph
absenc
target
membran
inactiv
viru
fusion
bron
et
al
corver
et
al
di
simon
buchmeier
kort
et
al
nir
et
al
stegmann
et
al
puri
et
al
virus
fuse
low
ph
inactiv
method
viral
fusion
protein
inactiv
low
ph
undergo
irrevers
conform
chang
case
ha
result
insert
fusion
peptid
viral
membran
kort
et
al
weber
et
al
fourth
test
assess
whether
cell
express
viral
fusion
protein
fuse
cellcel
fusion
observ
light
fluoresc
microscopi
frey
et
al
melikyan
et
al
moth
et
al
score
gene
report
assay
monitor
interact
compon
fuse
cell
earp
et
al
feng
et
al
nussbaum
et
al
although
cellcel
fusion
assay
rel
simpl
perform
result
alway
correl
viruscel
fusion
infect
earp
et
al
lavillett
et
al
schmid
et
al
mani
envelop
virus
requir
low
ph
fuse
target
cell
gener
establish
control
experi
use
approach
describ
sect
virus
fuse
neutral
ph
includ
paramyxovirus
herpesvirus
coronavirus
poxvirus
retrovirus
tabl
hernandez
et
al
mcclure
et
al
stein
et
al
taguchi
matsuyama
fusion
protein
virus
activ
via
specif
interact
one
receptor
target
cell
membran
hernandez
et
al
hunter
stein
et
al
virus
fuse
neutral
ph
thought
plasma
membran
howev
may
also
abl
fuse
neutralph
intracellular
compart
eg
caveosom
access
newli
recogn
endocyt
pathway
pelkman
heleniu
shin
abraham
see
also
chapter
sieczkarski
whittak
volum
import
note
howev
virus
fuse
neutral
ph
may
also
possess
abil
fuse
low
ph
earp
et
al
fackler
peterlin
date
neutralph
fusion
found
display
sharp
temperatur
threshold
littl
fusion
occur
recent
third
model
propos
activ
alpharetrovirus
model
activ
alpharetrovir
env
begin
receptor
bind
neutral
ph
complet
exposur
low
ph
moth
et
al
role
low
ph
twostep
model
deriv
two
key
observ
continu
presenc
endosom
acidif
inhibitor
prevent
product
alpharetrovir
revers
transcript
cell
express
env
cell
express
viral
receptor
form
larg
syncytia
exposur
low
ph
moth
et
al
recent
work
indic
alpharetroviru
fusion
proceed
lipid
mix
stage
neutral
ph
earp
et
al
receptor
bind
low
ph
sequenti
induc
distinct
conform
chang
alpharetrovi
env
matsuyama
et
al
current
work
focus
determin
precis
role
low
ph
fusion
cascad
viral
fusion
protein
contain
rel
larg
ectodomain
gener
singl
transmembran
domain
contain
cytoplasm
tail
far
two
major
group
class
class
ii
defin
base
structur
criteria
lescar
et
al
tabl
class
fusion
protein
synthes
precursor
cleav
two
subunit
host
cell
proteas
case
eg
influenza
ha
two
subunit
remain
associ
disulfid
bond
other
eg
hiv
env
two
subunit
remain
associ
noncoval
interact
proteolyt
process
event
gener
two
subunit
critic
creat
metast
state
fusion
protein
chen
et
al
class
fusion
protein
exist
rel
long
trimer
spike
metast
activ
state
metast
state
project
perpendicularli
viral
membran
activ
form
fusion
subunit
known
class
fusion
protein
highli
ahel
final
lowestenergi
refer
postfus
form
fig
contain
sixhelix
bundl
bullough
et
al
carr
kim
sixhelix
bundl
contain
rel
long
central
ntermin
trimer
coiledcoil
eg
hiv
env
siv
env
paramyxoviru
f
form
sixhelix
bundl
extend
membran
proxim
end
ie
three
ctermin
helic
fig
green
pack
groov
central
coiledcoil
fig
blue
other
display
mixtur
helic
nonhel
segment
pack
groov
central
coiledcoil
exampl
subunit
influenza
ha
contain
rel
small
sixhelix
bundl
fig
greenblu
membran
distal
end
follow
extend
chain
fig
yellow
pack
groov
extend
ntermin
membran
proxim
end
central
coiledcoil
fig
variat
postfus
form
class
fusion
protein
often
refer
trimer
hairpin
eckert
kim
gener
structur
class
ii
fusion
protein
quit
differ
class
fusion
protein
wellcharacter
exampl
envelop
glycoprotein
e
tickborn
enceph
tbe
viru
biosynthesi
tbe
e
second
viral
membran
glycoprotein
precursor
membran
protein
prm
form
heterodim
virion
lamb
colman
lawrenc
ture
host
cell
proteas
cleav
prm
result
reorgan
protein
viral
surfac
allison
et
al
prm
cleavag
e
protein
exist
metast
homodim
ectodomain
dimer
orient
antiparallel
one
anoth
contrast
trimer
class
fusion
protein
spike
ectodomain
e
homodim
lie
parallel
viral
membran
close
surfac
tbe
e
protein
compos
mostli
bstrand
structur
rey
et
al
architectur
semliki
forest
viru
sfv
spike
anoth
wellcharacter
class
ii
fusion
protein
similar
tbe
e
case
metast
oligom
heterodim
two
membraneanchor
protein
associ
small
protein
sect
discuss
exampl
viral
fusion
protein
employ
differ
fusion
mechan
detail
includ
highresolut
structur
avail
complet
nativ
metast
wilson
et
al
activ
bullough
et
al
chen
et
al
form
influenza
ha
viral
surfac
ha
exist
trimer
heterodim
fig
heterodim
consist
contain
receptor
bind
domain
fig
gray
contain
fusion
peptid
fig
red
transmembran
domain
locat
cterminu
nativ
neutral
ph
structur
fusion
peptid
buri
within
ha
oligom
three
long
helic
one
monom
come
togeth
form
triplestrand
coiledcoil
metast
trimer
fig
b
blue
green
lowphinduc
conform
chang
within
influenza
ha
depict
gray
fusion
peptid
red
residu
coiledcoil
blue
ctermin
helix
color
green
ctermin
extend
region
yellow
transmembran
domain
shown
attach
ctermin
end
indic
c
model
conform
chang
nativ
metast
structur
ha
fusion
peptid
buri
within
trimer
interfac
act
clamp
hold
metast
state
larg
shield
illumin
core
cartoon
portion
cover
simpl
gray
line
b
exposur
low
ph
headgroup
separ
allow
expuls
fusion
peptid
c
looptohelix
transit
caus
fusion
peptid
reposit
one
end
bind
target
membran
helixtoloop
transit
caus
ctermin
helix
ctermin
extend
region
revers
direct
bind
groov
coiledcoil
antiparallel
orient
exposur
low
ph
ha
undergo
dramat
conform
chang
globular
head
domain
separ
releas
clamp
hold
metast
state
fig
result
fusion
peptid
expos
fig
red
top
extend
triplestrand
coiledcoil
posit
interact
target
membran
helixtoloop
transit
caus
short
helix
fig
green
ctermin
extend
region
yellow
flip
run
antiparallel
central
coiledcoil
bullough
et
al
result
fusion
peptid
transmembran
domain
brought
close
proxim
end
molecul
fig
mani
region
ha
import
fusion
fusion
peptid
critic
hydrophob
attach
viru
target
membran
sect
mutat
prevent
globular
head
domain
separ
godley
et
al
kembl
et
al
bloop
helix
transit
gruenk
et
al
qiao
et
al
ctermin
extend
region
pack
groov
final
coiledcoil
borregodiaz
et
al
park
et
al
ablat
abil
ha
reach
lipid
mix
stage
fusion
model
gruenk
et
al
convers
ha
prehairpin
intermedi
fig
allow
ha
bind
target
membran
convers
hairpin
structur
fig
drive
format
open
fusion
pore
like
influenza
ha
hiv
env
synthes
singlechain
precursor
cleav
biosynthesi
yield
nativ
metast
hiv
env
trimer
heterodim
receptor
bind
subunit
fusion
subunit
env
activ
fusion
neutral
ph
sequenti
bind
coreceptor
chemokin
receptor
bind
env
caus
conform
chang
env
permit
bind
coreceptor
coreceptor
bind
addit
conform
chang
occur
env
lead
fusion
eckert
kim
crystal
structur
exist
core
subunit
kwong
et
al
well
postfus
fig
step
form
chan
et
al
weissenhorn
et
al
howev
yet
crystal
structur
nativ
metast
env
trimer
therefor
detail
pictur
hiv
env
activ
via
receptor
interact
avail
presum
first
step
env
activ
separ
globular
head
domain
expuls
fusion
peptid
extens
prehairpin
intermedi
fig
step
sever
line
evid
indic
exist
prehairpin
intermedi
exampl
peptid
analog
ctermin
helix
fig
green
strongli
inhibit
hiv
fusion
infect
chan
kim
kilbi
et
al
also
synthet
peptid
correspond
ctermin
helix
coimmunoprecipit
hiv
env
engag
receptor
furuta
et
al
et
al
ctermin
helix
pack
antiparallel
fashion
groov
ntermin
coiledcoil
fig
step
ctermin
helic
extend
along
entir
length
ntermin
coiledcoil
pack
would
bring
fusion
peptid
transmembran
domain
close
togeth
transit
sixhelix
bundl
drive
membran
merger
melikyan
et
al
moreov
complet
sixhelix
bundl
need
form
robust
fusion
pore
mention
hiv
studi
primarili
use
epitop
access
assay
indic
engag
hiv
receptor
induc
con
target
cell
receptor
pictur
model
exposur
receptor
coreceptor
neutral
ph
env
undergo
conform
chang
result
exposur
fusion
peptid
step
insert
target
membran
step
multipl
env
may
cluster
step
form
fusion
site
addit
conform
chang
step
lead
format
sixhelix
bundl
result
hemifus
step
defin
mix
outer
leaflet
viral
cellular
membran
eventu
fusion
pore
form
step
enlarg
shown
format
chang
eckert
kim
xiang
et
al
remain
issu
receptoractiv
viral
fusion
protein
inform
transmit
receptor
bind
receptor
bind
subunit
fusion
subunit
transmiss
essenti
allow
rearrang
fusion
subunit
eg
sixhelix
bundl
format
drive
fusion
hiv
part
mechan
may
involv
reduct
one
disulfid
bond
abrahamyan
et
al
barbouch
et
al
fenouillet
et
al
gallina
et
al
murin
retrovir
env
prolinerich
hing
region
appear
relay
receptor
bind
inform
ntermin
ctermin
region
receptor
bind
subunit
su
barnett
cunningham
lavillett
et
al
prolinerich
region
su
link
tm
disulfid
bond
pinter
et
al
may
provid
relay
system
trigger
conform
chang
fusion
subunit
clearli
molecular
pathway
receptoractiv
fusion
protein
chang
metast
activ
form
need
defin
fig
show
work
model
hiv
envmedi
fusion
deriv
part
studi
influenza
ha
similar
hiv
fusion
model
eckert
kim
hypothesi
class
fusion
protein
employ
similar
mechan
note
howev
even
case
influenza
ha
altern
model
still
entertain
see
fig
jahn
et
al
furthermor
other
suggest
differ
class
fusion
protein
may
use
fundament
differ
mechan
chen
et
al
featur
predict
common
fusion
mechan
class
fusion
protein
fig
includ
convers
metast
state
activ
state
exposur
reposit
fusion
peptid
bind
target
bilay
recruit
sever
activ
fusion
protein
fusion
site
blumenth
et
al
dani
et
al
markov
et
al
markov
et
al
subsequ
conform
chang
result
close
apposit
fusion
peptid
transmembran
domain
viral
fusion
protein
thu
far
discuss
detail
contain
receptor
bind
domain
eg
subunit
hiv
env
within
fusion
protein
spike
case
receptor
bind
domain
resid
separ
viral
spike
paramyxovirus
attach
protein
spike
separ
fusion
f
protein
spike
paramyxovirus
requir
attach
protein
f
protein
fusion
bagai
lamb
paterson
et
al
case
attach
protein
must
come
paramyxoviru
fusion
protein
bossart
et
al
case
f
protein
suffici
fusion
enhanc
attach
protein
also
express
bagai
lamb
need
attach
protein
overcom
mutat
f
protein
paterson
et
al
seth
et
al
conduct
fusion
reaction
paterson
et
al
wharton
et
al
paramyxoviru
fusion
protein
thu
repres
special
case
receptoractiv
fusion
protein
receptor
activ
commun
one
viral
spike
glycoprotein
anoth
f
protein
proteolyt
cleav
biosynthesi
gener
two
disulfidebond
subunit
f
f
begona
ruizarguello
et
al
gonzalezrey
et
al
lamb
found
metast
trimer
dimer
baker
et
al
virion
suggest
bind
attach
protein
host
cell
receptor
caus
conform
chang
protein
turn
caus
activ
conform
chang
metast
f
protein
lamb
russel
et
al
takimoto
et
al
exact
mechan
attach
protein
activ
f
protein
known
sever
group
provid
evid
cross
talk
attach
f
protein
bossart
et
al
deng
et
al
mcginn
et
al
stonehulsland
morrison
takimoto
et
al
yao
et
al
postfus
form
f
protein
paramyxoviru
contain
sixhelix
bundl
baker
et
al
similar
hiv
env
kilbi
et
al
munozbarroso
et
al
retrovir
fusion
protein
earp
et
al
netter
peptid
analog
nand
ctermin
helic
paramyxoviru
sixhelix
bundl
potent
inhibitor
fusion
infect
bossart
et
al
joshi
et
al
lambert
et
al
young
et
al
also
case
hiv
env
melikyan
et
al
recent
studi
show
convers
f
protein
sixhelix
bundl
drive
membran
fusion
issu
yet
address
paramyxovirus
structur
complet
nativ
metast
f
trimer
convert
activ
form
first
glimps
metast
postfus
state
f
trimer
came
em
observ
respiratori
syncyti
viru
rsv
f
protein
prepar
purifi
recombin
f
protein
contain
coneshap
rod
lollipop
shape
structur
storag
appear
shift
coneshap
lollipop
shape
structur
calder
et
al
examin
f
complex
specif
monoclon
antibodi
suggest
lollipop
structur
contain
sixhelix
bundl
compos
nand
ctermin
heptad
repeat
calder
et
al
highresolut
structur
f
protein
ectodomain
recent
present
chen
et
al
protein
use
analysi
contain
mixtur
precursor
f
proteolyt
cleav
f
also
appar
lack
second
heptad
repeat
form
chelix
postfus
form
trimer
f
protein
structur
fundament
differ
influenza
ha
ntermin
end
coiledcoil
posit
near
viral
membran
end
molecul
ie
opposit
orient
coiledcoil
metast
ha
trimer
f
protein
structur
repres
nativ
metast
f
trimer
suggest
mechan
fusion
activ
f
fundament
differ
ha
chen
et
al
addit
work
need
test
idea
known
class
ii
fusion
protein
activ
low
ph
howev
mechan
class
ii
fusion
protein
initi
activ
quit
differ
mechan
class
fusion
protein
initi
activ
exampl
ectodomain
tbe
glycoprotein
form
antiparallel
dimer
lie
parallel
close
viral
membran
fig
low
ph
tbe
e
homodim
convert
e
homotrim
allison
et
al
heinz
allison
stiasni
et
al
transform
thought
occur
two
step
dissoci
e
homodim
follow
reassoci
e
trimer
stiasni
et
al
membran
bind
occur
dimer
dissoci
promot
format
e
homotrim
stiasni
et
al
homotrim
format
may
involv
interact
ahelic
stem
region
e
protein
allison
et
al
sfv
fusion
protein
also
convert
dimer
trimer
fusion
activ
nativ
virion
exist
tight
heterodimer
complex
second
membran
protein
exposur
low
ph
dissoci
chang
conform
form
highli
stabl
homotrim
ahn
et
al
kielian
process
bind
hydrophob
fusion
peptid
target
membran
mediat
fusion
similar
tbe
e
appear
bind
target
bilay
foster
format
activ
homotrim
kielian
kielian
et
al
fusion
peptid
transmembran
domain
appear
import
homotrim
format
kielian
et
al
kielian
et
al
sjoberg
garoff
thu
class
class
ii
viral
fusion
protein
appear
function
trimer
fusion
propos
activ
tbe
e
heleniu
sfv
stand
trimer
spike
present
fusion
peptid
target
membran
fig
right
would
analog
fig
step
occur
kuhm
et
al
note
possibl
dimer
trimer
transit
exist
exampl
involv
rel
movement
domain
hing
region
recent
develop
regard
fusion
mechan
class
ii
fusion
protein
see
bressanelli
et
al
gibbon
et
al
modi
et
al
spike
would
refold
bring
viral
cellular
membran
togeth
eg
analog
step
fig
recent
evid
indic
inde
case
bressanelli
et
al
gibbon
et
al
modi
et
al
thu
far
focus
condit
elicit
viral
fusion
reaction
conform
chang
viral
fusion
protein
necessari
fusion
howev
viral
cellular
bilay
membran
merg
fusion
lipid
bilay
stabl
structur
fuse
spontan
fusion
protein
evolv
catalyz
necessari
lipid
rearrang
review
lipid
rearrang
model
focu
role
differ
region
viral
fusion
protein
choreograph
structur
chang
membran
undergo
throughout
fusion
cascad
fig
favor
model
lipid
transit
state
membran
fusion
stalk
model
model
two
oppos
membran
bend
toward
creat
dimpl
view
tran
surfac
nippl
view
ci
surfac
fig
step
nippl
continu
bend
meet
two
ci
leaflet
merg
creat
lipid
stalk
see
fig
kozlovski
kozlov
proce
state
local
hemifus
fig
step
second
step
transient
fusion
pore
form
give
rise
stabl
pore
fig
step
first
direct
visual
lipid
stalk
intermedi
achiev
electron
diffract
studi
effect
sequenti
dehydr
lipid
bilay
compos
lipid
neg
spontan
curvatur
yang
huang
stalk
intermedi
stabl
intermedi
rel
humid
result
suggest
format
lipid
stalk
transit
conform
equat
pore
format
requir
extern
forc
cellular
membran
spontan
neg
curvatur
highli
hydrat
membran
curvatur
promot
introduc
defect
contact
bilay
thu
role
fusion
protein
includ
pull
fuse
bilay
toward
one
anoth
dimpl
dehydr
membran
creat
membran
defect
lower
energi
barrier
stalk
pore
format
two
intermedi
hiv
fusion
trap
one
two
membran
join
activ
env
yet
fuse
melikyan
et
al
one
small
labil
pore
form
either
expand
stabl
robust
pore
return
prefus
state
observ
suggest
role
fusion
protein
format
stabil
fusion
stalk
fusion
pore
mechan
small
pore
enlarg
known
howev
sever
possibl
propos
one
initi
fusion
pore
form
small
number
activ
fusion
protein
addit
activ
fusion
protein
move
fusion
site
buttress
stabil
pore
therebi
allow
expand
kozlov
chernomordik
anoth
possibl
multipl
small
fusion
pore
coalesc
form
larger
one
support
em
visual
hamedi
fusion
multipl
dimplesnippl
arrang
circularli
lipid
fragment
seen
center
fusion
ring
kanaseki
et
al
discuss
role
fusion
protein
fusion
cascad
fig
includ
pull
fuse
bilay
toward
one
anoth
dimpl
creat
membran
defect
lower
energi
barrier
stalk
format
fusion
pore
openingenlarg
fusion
peptid
transmembran
domain
must
remain
stabli
associ
target
viral
membran
respect
fusion
occur
fusion
peptid
stabli
associ
target
bilay
fig
step
envis
rearrang
fusion
protein
ectodomain
bring
fusion
peptid
transmembran
domain
close
togeth
fig
step
result
dimpl
membran
toward
one
anoth
addit
serv
critic
membran
anchor
fusion
peptid
transmembran
domain
like
creat
membran
defect
facilit
next
stage
fusion
review
inform
structur
function
fusion
peptid
transmembran
domain
fusion
also
review
evid
juxtamembran
sequenc
side
transmembran
domain
particip
fusion
fusion
peptid
rel
apolar
sequenc
interact
membran
central
viral
fusion
reaction
martin
ruysschaert
martin
et
al
skehel
et
al
white
fig
b
characterist
viral
fusion
peptid
select
viral
fusion
peptid
sequenc
ntermin
intern
fusion
peptid
sequenc
align
accord
first
noncharg
residu
b
model
ha
fusion
peptid
structur
target
membran
ph
adapt
tamm
et
al
fusion
peptid
red
resid
target
membran
kink
structur
compos
two
ahelic
penetr
outer
leaflet
glycin
ridg
depict
yellow
box
hydrophob
interior
face
cyan
oval
surfac
charg
residu
blue
squar
c
denot
direct
ectodomain
classifi
ntermin
intern
depend
locat
within
fusion
subunit
tabl
although
fusion
peptid
highli
conserv
within
viru
famili
littl
sequenc
similar
fusion
peptid
differ
famili
fig
gener
howev
fusion
peptid
contain
high
percentag
glycin
andor
alanin
well
sever
critic
bulki
hydrophob
residu
martin
ruysschaert
martin
et
al
skehel
et
al
tamm
han
tamm
et
al
signific
bodi
work
emerg
structur
function
synthet
fusion
peptid
martin
ruysschaert
martin
et
al
skehel
et
al
tamm
han
tamm
et
al
synthet
fusion
peptid
disord
solut
order
ahelix
andor
bsheet
associ
membran
ntermin
fusion
peptid
studi
insert
membran
obliqu
angl
penetr
inner
leaflet
membran
gener
mutat
abrog
fusion
reduc
abil
synthet
fusion
peptid
insert
obliqu
angl
disrupt
membran
martin
et
al
contradictori
conclus
precis
structur
synthet
fusion
peptid
membran
like
stem
gener
low
solubl
peptid
aqueou
solut
differ
experiment
method
employ
tamm
et
al
circumv
solubl
problem
polar
sequenc
ad
ctermin
end
influenza
ha
fusion
peptid
render
solubl
aqueou
hydrophob
environ
han
et
al
ph
ha
fusion
peptid
consist
ntermin
helix
kink
short
ctermin
helix
fig
nand
ctermin
helic
penetr
outer
leaflet
target
bilay
kink
remain
phospholipid
surfac
interior
lipidfac
surfac
kink
line
hydrophob
residu
conserv
glycin
form
ridg
along
outer
face
ntermin
helix
three
charg
residu
also
found
outer
face
fig
ha
conserv
glycin
begin
fusion
peptid
chang
valin
mediat
fusion
chang
serin
ha
mediat
hemifus
form
small
nonexpand
fusion
pore
qiao
et
al
skehel
et
al
interestingli
mutant
fusion
peptid
membraneassoci
structur
orient
significantli
differ
wildtyp
fusion
peptid
li
et
al
simul
suggest
similar
membran
penetr
orient
hiv
fusion
peptid
two
fusiondefect
mutant
kamath
wong
addit
signific
number
apolar
residu
mani
intern
fusion
peptid
contain
conserv
prolin
near
center
fig
mutagenesi
prolin
avian
sarcomaleukosi
viru
aslv
enva
fusion
peptid
suggest
stabil
bturn
coupl
observ
mutat
two
cystein
flank
fusion
peptid
abolish
fusion
activ
suggest
intern
enva
fusion
peptid
exist
loop
structur
stabil
disulfid
bond
abil
ebola
viru
fusion
protein
also
contain
intern
fusion
peptid
support
infect
similarli
inhibit
central
prolin
flank
cystein
mutat
ito
et
al
jeffer
et
al
similar
mutat
prolin
within
predict
turn
segment
candid
fusion
peptid
vsv
g
also
significantli
decreas
fusion
abolish
infect
fredericksen
whitt
idea
loop
structur
intern
fusion
peptid
support
known
loop
structur
tbe
e
sfv
ei
fusion
peptid
rey
et
al
lescar
et
al
case
two
noncontigu
sequenc
loop
may
function
collect
fusion
peptid
gaudin
et
al
li
et
al
like
ntermin
fusion
peptid
intern
fusion
peptid
contain
signific
number
glycin
hydrophob
residu
fig
chang
either
two
glycin
within
sfv
fusion
peptid
alanin
alter
ph
threshold
fusion
chang
one
glycin
aspart
acid
abolish
fusion
duffu
et
al
kielian
et
al
alter
hydrophob
residu
begin
middl
end
intern
aslv
enva
fusion
peptid
charg
residu
impair
abil
enva
mediat
fusion
hernandez
white
similarli
tryptophan
glycin
critic
ebola
gpmediat
infect
ito
et
al
also
bulki
hydrophob
residu
need
tip
tbe
e
fusion
peptid
loop
rey
et
al
fig
red
collect
result
suggest
intern
fusion
peptid
function
loop
requir
mixtur
hydrophob
flexibl
residu
similar
found
ntermin
fusion
peptid
fusion
peptid
appear
act
sever
step
along
fusion
pathway
demonstr
mutant
apolar
fusion
peptid
residu
chang
charg
residu
freed
et
al
geth
et
al
hernandez
white
schoch
blumenth
fusion
peptid
clearli
play
import
role
anchor
fusion
protein
target
membran
fig
step
energi
provid
insert
fusion
peptid
singl
ha
trimer
membran
would
suffici
initi
stalk
format
guntherausborn
et
al
fusion
peptid
may
also
assist
creat
stalk
displac
water
lipidwat
interfac
thu
decreas
repuls
forc
two
fuse
membran
tamm
han
fusion
peptid
may
also
function
fusion
pore
open
support
possibl
observ
ha
mutant
chang
serin
mediat
extens
lipid
content
mix
qiao
et
al
furthermor
defect
syncytium
format
infect
observ
hiv
env
harbor
mutat
fusion
peptid
freed
et
al
biophys
studi
compar
synthet
fusion
peptid
harbor
mutat
wildtyp
peptid
suggest
requir
fusion
peptid
aggreg
creation
hiv
fusion
pore
pereira
et
al
studi
chimer
fusion
protein
suggest
transmembran
domain
viral
fusion
protein
requir
specif
sequenc
support
fusion
armstrong
et
al
refer
therein
contrast
studi
glycosylphosphatidylinositol
gpi
anchor
fusion
protein
demonstr
strict
requir
proteinac
membran
anchor
fusion
protein
effici
mediat
transit
hemifus
full
fusion
kembl
et
al
melikyan
et
al
tong
compan
also
appear
minimum
length
fusion
protein
transmembran
domain
abl
support
transit
armstrong
et
al
west
et
al
therefor
suggest
fusion
protein
transmembran
domain
must
span
leaflet
viral
bilay
mediat
fusion
pore
open
armstrong
et
al
transmembran
domain
fusion
protein
appear
specif
amino
acid
requir
fusion
function
exampl
conserv
posit
charg
residu
middl
transmembran
domain
certain
retrovir
env
appear
import
abil
mediat
fusion
infect
einfeld
hunter
owen
et
al
pietschmann
et
al
west
et
al
two
glycin
residu
transmembran
domain
vsvg
appear
import
transit
hemifus
full
fusion
cleverley
lenard
studi
use
synthet
peptid
correspond
mutant
vsvg
transmembran
domain
dennison
et
al
suggest
vsvg
transmembran
domain
lower
energi
barrier
fusion
stabil
transient
fusion
pore
therebi
promot
convers
stabl
fusion
pore
two
glycin
may
allow
vsvg
transmembran
domain
adopt
altern
conform
differ
condit
flexibl
may
import
function
transmembran
domain
ha
japan
melikyan
et
al
armstrong
et
al
strain
influenza
appear
requir
glycin
near
middl
abil
adopt
altern
conform
also
invok
explain
requir
prolin
near
middl
transmembran
domain
murin
leukemia
viru
mlv
env
glycoprotein
taylor
sander
observ
mutat
fusion
peptid
transmembran
domain
armstrong
et
al
baker
et
al
tamm
et
al
impair
abil
mediat
full
fusion
fig
step
suggest
apolar
domain
function
transit
hemifus
full
fusion
initi
fusion
peptid
appear
insert
outer
leaflet
target
membran
tamm
han
propos
transmembran
domain
fusion
peptid
close
membran
merger
may
interact
stabil
fusion
pore
tamm
et
al
zhou
et
al
case
fusion
peptid
might
span
leaflet
fuse
membran
final
conform
tamm
et
al
sever
line
evid
suggest
ectodomain
sequenc
lie
transmembran
domain
certain
viral
fusion
protein
may
import
fusion
sequenc
tend
high
proport
tryptophan
aromat
residu
predict
partit
interfaci
region
membran
suarez
et
al
inde
synthet
peptid
contain
juxtamembran
ectodomain
sequenc
hiv
env
ebola
gp
partit
interfaci
region
target
membran
saezcirion
et
al
saezcirion
et
al
schibli
et
al
suarez
et
al
mutat
three
tryptophan
within
region
hiv
abrog
infect
appar
inhibit
fusion
pore
enlarg
munozbarroso
et
al
extend
hiv
ctermin
heptad
repeat
peptid
includ
tryptophanrich
juxtamembran
ectodomain
sequenc
appear
increas
potenc
peptid
inhibitor
fusion
kliger
et
al
suggest
extend
heptad
repeat
peptid
potent
could
bind
two
site
hiv
env
ntermin
coiledcoil
second
yet
unidentifi
site
kliger
et
al
like
effect
peptid
late
stage
fusion
prevent
format
requir
structur
env
provid
addit
membran
destabil
manner
partit
juxtamembran
sequenc
interfaci
region
membran
may
promot
transit
stalk
intermedi
fusion
pore
see
sect
specif
cytoplasm
tail
sequenc
appear
essenti
modul
late
stage
fusion
cytoplasm
tail
shown
influenc
transit
hemifus
full
fusion
fusion
pore
enlarg
dutch
lamb
kozerski
et
al
virus
mechan
cytoplasm
tail
may
influenc
later
stage
fusion
known
studi
use
synthet
peptid
suggest
direct
interact
cytoplasm
tail
viral
membran
chen
et
al
fujii
et
al
gawrisch
et
al
haffar
et
al
other
shown
cytoplasm
tail
influenc
structur
ectodomain
fusion
protein
aguilar
et
al
edward
et
al
abil
cytoplasm
tail
affect
ectodomain
structur
clearli
manifest
viral
fusion
protein
harbor
fusionsuppress
sequenc
sequenc
found
fusion
protein
mlv
ragheb
anderson
type
c
retrovirus
bobkova
et
al
lentivirus
kim
et
al
luciw
et
al
paramyxoviru
f
protein
tong
et
al
cytoplasm
tail
mlv
env
cleav
viru
bud
schultz
rein
mlv
env
harbor
uncleav
cytoplasm
tail
induc
fusion
yang
compan
although
virus
lack
fusionsuppress
sequenc
display
increas
cellcel
fusion
suscept
neutral
antibodi
januszeski
et
al
li
et
al
rein
et
al
yang
compan
impair
abil
sustain
multipl
round
infect
cathomen
et
al
freed
martin
piller
et
al
acyl
cytoplasm
tail
also
affect
fusion
appar
late
stage
exampl
mutant
ha
japan
strain
influenza
three
normal
palmitoyl
cystein
residu
mutat
appear
fuse
normal
monitor
dye
redistribut
assay
melikyan
et
al
howev
electrophysiolog
measur
reveal
fusion
pore
form
mutant
ha
flicker
like
form
wtha
melikyan
et
al
similar
mutat
ha
influenza
subtyp
shown
respect
inhibit
syncytia
format
fischer
et
al
transit
hemifus
full
fusion
palmitoyl
hiv
env
also
shown
import
env
incorpor
virion
infect
rousso
et
al
thu
acyl
cytoplasm
tail
appear
multipl
effect
viral
fusion
reaction
detail
complet
understood
lipid
raft
plasma
membran
microdomain
enrich
cholesterol
glycosphingolipid
satur
acyl
chain
organiz
platform
varieti
cellular
function
includ
sort
membran
protein
signal
brown
london
although
grow
evid
certain
virus
employ
raft
raftlik
membran
microdomain
viru
assembl
suomalainen
question
whether
structur
requir
site
fusion
target
cell
less
clear
consid
role
raft
fusion
two
envelop
virus
sfv
hiv
import
consid
whether
cholesterol
andor
sphingolipid
requir
fusion
found
lipid
raft
serv
purpos
exampl
cholesterol
may
interact
directli
fusion
protein
therebi
facilit
insert
target
membran
altern
need
cholesterol
sphingolipid
could
reflect
abil
raft
structur
concentr
viral
receptor
third
possibl
cholesterol
impart
membran
fluiditi
biophys
properti
need
lower
energi
barrier
fusion
sfv
requir
cholesterol
sphingolipid
target
membran
fusion
moieti
enabl
sfv
spike
protein
undergo
conform
chang
bind
target
membran
ahn
et
al
kielian
et
al
recent
studi
shown
hydrophob
associ
target
bilay
sfv
glycoprotein
ectodomain
associ
membran
structur
properti
similar
raft
howev
care
studi
use
liposom
prepar
specif
cholesterol
sphingolipid
analog
demonstr
cholesterol
sphingolipid
requir
target
membran
correl
abil
form
lipid
raft
ahn
et
al
relat
conclus
drawn
base
fusion
activ
sfv
sindbi
viru
liposom
waart
et
al
virus
requir
cholesterol
sphingolipid
target
membran
appear
insert
fusion
peptid
vashishtha
et
al
case
hiv
sever
studi
suggest
need
raftlik
membran
microdomain
viru
entri
kozak
et
al
popik
et
al
deplet
plasma
membran
cholesterol
target
cell
result
reduc
level
viru
infect
cellcel
fusion
studi
conclud
raft
necessari
hiv
entri
percheranci
et
al
viard
et
al
one
studi
deplet
cholesterol
cell
express
low
level
viru
receptor
inhibit
hiv
envmedi
cellcel
fusion
deplet
cholesterol
cell
express
high
level
viru
receptor
viard
et
al
therefor
conclud
raft
per
se
need
fusion
rather
presenc
raftlik
structur
plasma
membran
may
concentr
viru
receptor
previou
work
shown
critic
densiti
hiv
receptor
requir
fusion
infect
reev
et
al
clearli
work
need
clarifi
role
raft
viruscel
fusion
entri
recent
becom
appar
larg
success
inhibit
hiv
infect
patient
jiang
et
al
kilbi
et
al
fusion
good
target
antivir
intervent
origin
conceptu
fusion
essenti
earli
step
viru
infecti
cycl
happen
exoplasm
space
strategi
design
inhibit
fusion
without
interf
host
cell
protein
fusion
inhibitor
function
inhibit
sixhelix
bundl
format
other
function
prevent
earlier
conform
chang
viral
fusion
protein
peptid
also
known
fuzeon
correspond
ctermin
helix
hiv
env
fig
green
work
prevent
sixhelix
bundl
format
potent
inhibitor
infect
tissu
cultur
peptid
correspond
equival
region
retrovirus
well
sever
paramyxovirus
function
similarli
earp
et
al
russel
et
al
notabl
virus
shown
highli
suscept
chelix
peptid
inhibitor
function
neutral
ph
least
lipid
interact
stage
viruscel
fusion
earp
et
al
peptid
correspond
ntermin
helic
hiv
env
f
protein
also
inhibit
fusion
although
lower
potenc
lu
et
al
russel
et
al
mechan
inhibit
ntermin
peptid
still
consider
case
f
npeptid
appear
target
earlier
intermedi
cpeptid
strategi
consid
stabil
prehairpin
intermedi
fig
step
therebi
prevent
sixhelix
bundl
format
one
strategi
develop
antibodi
recogn
prehairpin
intermedi
gold
et
al
anoth
exemplifi
three
studi
develop
small
molecul
prevent
sixhelix
bundl
format
debnath
et
al
eckert
et
al
ferrer
et
al
three
studi
target
hydrophob
pocket
groov
central
coiledcoil
hiv
import
interact
ctermin
helix
postfus
form
first
approach
two
organ
compound
identifi
screen
effort
conduct
conjunct
molecular
dock
method
identifi
small
molecul
fit
target
site
debnath
et
al
second
approach
replac
three
residu
ctermin
helix
bind
hydrophob
pocket
organ
moieti
gener
combinatori
chemistri
ferrer
et
al
third
approach
use
mirror
imag
phage
display
librari
identifi
small
damino
acid
contain
peptid
bind
pocket
eckert
et
al
although
none
small
molecul
identifi
date
potent
preced
set
attain
goal
effort
block
fusion
activ
influenza
base
idea
maintain
ha
nativ
metast
state
prevent
fusion
infect
first
trial
target
site
ha
includ
part
fusion
peptid
use
antibodybas
assay
monitor
fusion
peptid
exposur
compound
tertbutylhydroquinon
tbhq
prevent
first
stage
ha
conform
chang
inhibit
infect
discov
bodian
et
al
followup
studi
target
site
near
bloop
ha
yield
addit
inhibitor
wherea
function
like
tbhq
second
class
identifi
appear
push
ha
inact
state
hoffman
et
al
random
screen
influenza
viru
identifi
inhibitor
appear
function
similarli
tbhq
latter
case
bind
site
inhibitor
map
vicin
fusion
peptid
cianci
et
al
small
molecul
inhibit
conform
chang
ha
identifi
staschk
et
al
date
none
ha
inhibitor
block
ha
subtyp
none
ic
valu
submicromolar
rang
yet
clear
whether
latter
limit
repres
fundament
difficulti
inhibit
viral
fusion
protein
function
low
ph
addit
small
molecul
approach
describ
antibodi
prevent
fusioninduc
chang
viral
glycoprotein
describ
first
exampl
antibodi
prevent
lowphinduc
fusion
west
nile
viru
model
liposom
gollin
porterfield
recent
fab
fragment
bind
two
monom
shown
prevent
earli
conform
chang
influenza
ha
barbey
martin
et
al
separ
globular
head
domain
fig
describ
antibodi
develop
like
block
sixhelix
bundl
format
case
hiv
env
gold
et
al
goal
review
give
reader
appreci
divers
viral
fusion
mechan
recogn
common
underli
principl
also
summar
known
lipid
dynam
lipid
structur
involv
fusion
also
briefli
overview
recent
develop
target
viral
fusion
antivir
strategi
clearli
much
need
know
viral
fusion
protein
viral
fusion
reaction
design
antifus
agent
end
review
enumer
press
issu
question
remain
viral
fusion
major
goal
determin
highresolut
structur
complet
ectodomain
metast
trimer
class
viral
fusion
protein
addit
influenza
ha
structur
complet
paramyxoviru
f
complet
retrovir
env
ectodomain
highli
inform
current
lack
detail
molecular
descript
receptor
activ
viral
fusion
protein
neutral
ph
second
goal
delin
mechan
class
ii
viral
fusion
protein
transit
recent
describ
low
ph
form
bressanelli
et
al
gibbon
et
al
modi
et
al
mediat
hemifus
fusion
pore
open
mechan
yet
unclassifi
viral
fusion
protein
includ
virus
rhabdovirus
eg
vsv
need
one
protein
promot
fusion
well
complic
virus
herpesvirus
poxvirus
requir
multipl
viral
glycoprotein
ensu
year
also
bring
complet
understand
viral
fusion
protein
interact
target
membran
bilay
class
ii
fusion
protein
insert
intern
fusion
peptid
target
membran
loop
bressanelli
et
al
gibbon
et
al
modi
et
al
predict
intern
fusion
protein
class
fusion
protein
ebola
avian
retrovirus
form
disulfidebond
loop
structur
weisenhorn
et
al
mutagenesi
work
support
predict
jeffer
et
al
remain
seen
high
resolut
structur
studi
whether
intern
fusion
peptid
class
class
ii
class
fusion
protein
interact
target
bilay
disulfid
bond
stabil
loop
final
expect
major
develop
further
concept
target
fusion
weapon
pathogen
envelop
virus
particular
emphasi
like
develop
small
molecul
inhibitor
use
combinatori
chemistri
conjunct
highthroughput
screen
interest
learn
whether
small
molecul
fusion
inhibitor
identifi
block
entri
virus
fuse
endosom
respons
low
ph
challeng
lowphactiv
class
fusion
protein
influenza
ha
well
known
class
ii
fusion
protein
stay
tune
like
excit
develop
understand
viral
fusion
mechan
well
develop
antifus
antivir
year
ahead
dennison
sm
greenfield
n
lenard
j
lentz
br
